{xtd_wp_head}
Skip to content
About
Technology
Innovators
Students
Industry
Startups
Available Technology

Biomedical, Biotechnology

Improved Differentiation of Stem Cells into Cardiac Muscle Cells for Cardiac Tissue Repair

Inventors: Dr. Ying Mei

Market Overview

This approach advances the maturation of stem cells or progenitor cells, cells that differentiate like stem cells, to produce functional, biocompatible cardiomyocytes for the repair of damaged cardiac tissue. Cardiomyocytes are specialized cardiac muscle cells essential for cardiac muscle health. Cardiovascular disease, the leading cause of death worldwide, kills one in four Americans annually. A heart attack alone irreversibly destroys one billion cardiomyocytes, which can cause heart failure. Recent research suggests progenitor cells have the potential for regeneration; however attempts to produce functional cardiomyocytes from these cells are limited by their immature phenotype and inability to generate sufficient tissue. Clemson University researchers and their cardiac research collaborators at the Medical University of South Carolina (MUSC) have developed an approach for producing functional, mature cardiomyocytes from progenitor cells by incorporating electrically conductive nanomaterials into scaffold free spheroids. By introducing trace amounts of novel electrically conductive nanowires (e-NWs) into cardiac spheroids, the potential for regeneration of damaged tissue from progenitor cells is possible.

Applications:

Cardiac tissue repair, in vitro drug screening

Technical Summary:

The incorporation of trace amounts of e-NWs into scaffold-free spheroids conditions immature stem or progenitor cells into functional, mature cardiomyocytes by creating a conductive microenvironment for them to mature. These electrically conductive spheroids initiate synchronized electrical signal propagation within the microtissues to improve functional assembly of cardiomyocytes. The e-NWs are biodegradable and help facilitate the formation of an electrically conductive network, leading to synchronized and significantly enhanced contraction for more advanced cellular, structural and contractile maturation of the progenitor cells.

Advantages:

  • Utilizes trace amounts of e-NWs, minimizing adverse effects and optimizing biocompatibility
  • Demonstrates biodegradable yet electrically conductive properties, accurately replicating the in vivo microenvironment
  • Enables synchronized electrical signal propagation, facilitating the development of functional issues

Download Printable PDF

Technology Overview

State of Development

In vitro studies

Patent Type

PCT

Category

Biomedical, Biotechnology

Serial Number

PCT/US2016/013647

CURF Reference No.

2014-091

Inventors

Dr. Ying Mei


For More Info, Contact:

curf@clemson.edu
(864)656-0797

Contact

Get Started
Ready to Get Started?

Contact our team at CURF

Contact CURF